首页> 外国专利> METHODS FOR TREATING POST-TRAUMATIC STRESS DISORDER IN PATIENTS VIA RENAL NEUROMODULATION

METHODS FOR TREATING POST-TRAUMATIC STRESS DISORDER IN PATIENTS VIA RENAL NEUROMODULATION

机译:通过神经调节治疗患者创伤后应激障碍的方法

摘要

Methods for treating post-traumatic stress disorder (PTSD) and/or for reducing a risk associated with developing PTSD in patients via therapeutic renal neuromodulation and associated systems are disclosed herein. Sympathetic nerve activity can contribute to several cellular and physiological conditions associated with PTSD as well as an increased risk of developing PTSD following a traumatic event. One aspect of the present technology is directed to methods for improving a patient's calculated risk score corresponding to a PTSD status in the patient. Other aspects are directed to reducing a likelihood of developing PTSD in patients presenting one or more PTSD risk factors. Renal sympathetic nerve activity can be attenuated to improve a patient's PTSD status or risk of developing PTSD. The attenuation can be achieved, for example, using an intravascularly positioned catheter carrying a therapeutic assembly configured to use, e.g., electrically-induced, thermally-induced, and/or chemically-induced approaches to modulate the renal sympathetic nerve.
机译:本文公开了用于治疗创伤后应激障碍(PTSD)和/或通过治疗性肾神经调节和相关系统降低与患者发生PTSD有关的风险的方法。交感神经活动可导致与PTSD相关的几种细胞和生理状况,以及在发生创伤事件后发展PTSD的风险增加。本技术的一方面针对用于改善与患者中的PTSD状态相对应的患者的计算出的风险评分的方法。其他方面旨在降低表现出一种或多种PTSD危险因素的患者发生PTSD的可能性。肾交感神经活动可以减弱,以改善患者的PTSD状况或发生PTSD的风险。例如,可以使用携带治疗组件的血管内定位导管来实现衰减,该治疗组件构造成使用例如电诱导,热诱导和/或化学诱导的方法来调节肾交感神经。

著录项

  • 公开/公告号US2019009091A1

    专利类型

  • 公开/公告日2019-01-10

    原文格式PDF

  • 申请/专利权人 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.I.;

    申请/专利号US201816026344

  • 发明设计人 DOUGLAS HETTRICK;MARCIA GALLAGHER;

    申请日2018-07-03

  • 分类号A61N1/36;A61B18/02;A61N1/05;A61N2/00;

  • 国家 US

  • 入库时间 2022-08-21 12:05:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号